<root>
	<PMID Version="1">25496832</PMID>
	<Summary>
		1: Park SL, Won SY, Song JH, Kambe T, Nagao M, Kim WJ, Moon SK. EPO geneexpression promotes proliferation, migration and invasion via thep38MAPK/AP-1/MMP-9 pathway by p21WAF1 expression in vascular smooth muscle cells.Cell Signal. 2015 Mar;27(3):470-8. doi: 10.1016/j.cellsig.2014.12.001. Epub 2014 Dec 8. PubMed PMID: 25496832.
	</Summary>
	<MeshHeadingList>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D018797">Cell Cycle Proteins</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D002460">Cell Line</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D002465">Cell Movement</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D049109">Cell Proliferation</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D019927">Cyclin E</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D050759">Cyclin-Dependent Kinase Inhibitor p21</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000037">antagonists &amp;amp; inhibitors</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
			<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D050760">Cyclin-Dependent Kinase Inhibitor p27</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D015536">Down-Regulation</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D004921">Erythropoietin</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000235">genetics</QualifierName>
			<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D007093">Imidazoles</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D020780">Matrix Metalloproteinase 9</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D019950">Mitogen-Activated Protein Kinase 1</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000037">antagonists &amp;amp; inhibitors</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D048052">Mitogen-Activated Protein Kinase 3</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000037">antagonists &amp;amp; inhibitors</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D032389">Myocytes, Smooth Muscle</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000166">cytology</QualifierName>
			<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D016328">NF-kappa B</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D015513">Oncogene Proteins</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D010766">Phosphorylation</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000187">drug effects</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D011725">Pyridines</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000494">pharmacology</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D034622">RNA Interference</DescriptorName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D034741">RNA, Small Interfering</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D018808">Transcription Factor AP-1</DescriptorName>
			<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	    <MeshHeading>
			<DescriptorName MajorTopicYN="N" UI="D048051">p38 Mitogen-Activated Protein Kinases</DescriptorName>
			<QualifierName MajorTopicYN="N" UI="Q000037">antagonists &amp;amp; inhibitors</QualifierName>
			<QualifierName MajorTopicYN="Y" UI="Q000378">metabolism</QualifierName>
	    </MeshHeading>
	</MeshHeadingList>
</root>
